Abstract:
Objective: To formulate and evaluate time dependent pulsatile drug delivery
system of Montelukast sodium to deliver the drug with biological rhythm of
asthma after predetermined lag time 6hours.
Experimental work: The core tablet of Montelukast sodium was prepared using
wet granulation containing Na CMC, Carbopol 934. Eudragi t S100 was used as
pH dependent for coating the core tablets. Total 9 batches were formulated as per
32full factorial design applied to check the effect of polymer (Na CMC,
Carbopol934) and level of Eudragit S100 coating on dependent variable lag time
of rupture of PRTs. These formulations were evaluated for physical parameters of
tablet, drug-excipient compatibility study, lag time of rupture of PRTs and invitro
drug release study.
Result and Discussion: The optimize formulation F7 (Na CMC 30mg & Carbopol
934 10mg in 6% Coating solution) provide lag time of rupture of PRTs was 6:10hr
and release the drug after rupture of outer coat. Stability study of the optimized
formulation indicates no significant differences in release profile and drug
content after a period of one month. Conclusion: Pulsatile drug delivery system of Montelukast Sodium formulated
using Carbopol 934 as swelling polymer and Na.CMC as disintegrate.
Formulation F7 can provide site specific delivery with zero-order release kinetics.